R&D investment

4 triples
GPTKB property

Random triples
Subject Object
gptkb:Sino_Biopharmaceutical_Limited over RMB 2 billion annually
gptkb:Grifols,_S.A. over €300 million annually
gptkb:Jiangsu_Hengrui_Medicine high
gptkb:Servier ~20% of revenue